Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Machine Learning Solution Assists Pathologists in Detection of Precancerous Cervical Lesions

By LabMedica International staff writers
Posted on 15 Jun 2023

Cervical cancer ranks as the fourth most prevalent cancer in women, with a reported 604,000 new occurrences in 2020, as per the World Health Organization (WHO). More...

Yet, it stands out as one of the most successfully preventable and treatable cancers, provided that it is detected early and managed appropriately. Therefore, early detection of pre-cancerous lesions is critical for disease prevention. Now, researchers have developed an innovative method using large, high-resolution images to detect crucial pre-cancerous lesions.

A team of researchers from INESC TEC (Porto, Portugal) and IMP Diagnostics (Porto, Portugal) has designed a machine learning solution to aid pathologists in detecting cervical dysplasia, making the diagnosis process of new samples fully automatic. This is among the first published works to utilize complete slides. The researchers set out to develop machine learning models to support the subjective classification of lesions in the squamous epithelium - the protective tissue layer against microorganisms - using whole-slide images (WSI) that contain information from the entire tissue.

The team developed a weakly-supervised methodology - a machine learning method that combines annotated and non-annotated data in the model training phase to classify cervical dysplasia. This technique proves particularly beneficial considering the difficulty of obtaining pathology data annotations: the large image sizes make the annotation process extremely time-consuming, tedious, and highly subjective. This methodology enables researchers to establish models with high performance, even when there's some missing information during the training phase. The resulting model can then grade cervical dysplasia, or abnormal cell growth on the surface, as low (LSIL) or high-grade intraepithelial squamous lesions (HSIL). Given the complexity and subjective nature of the classification process, these machine learning models can provide valuable assistance to pathologists. Furthermore, these systems could act as an early warning mechanism for suspicious cases, alerting pathologists to instances that warrant closer examination.

"In the detection of cervical dysplasia, this was one of the first published works that use the full slides, following an approach that includes the segmentation and subsequent classification of the areas of interest, making the diagnosis of new samples completely automatic," explained Sara Oliveira, a researcher at INESC TEC.

Related Links:
INESC TEC 
IMP Diagnostics 


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Immunofluorescence image of reactive astrocytes (red) in the area surrounding sEcad-high cancer cells (blue, center) (Photo courtesy of Debeb Laboratory)

Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis

Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.